Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma

Multiple myeloma (MM) is a hematological malignancy of monoclonal plasma cells that remains incurable. Standard treatments for MM include myeloablative regimens and autologous cell transplantation for eligible patients. A major challenge of these treatments is the relapse of the disease due to resid...

Descripción completa

Detalles Bibliográficos
Autores principales: Villa, Nancy.Y., Rahman, Masmudur M., Mamola, Joseph., D’Isabella, Julia, Goras, Elizabeth, Kilbourne, Jacquelyn, Lowe, Kenneth, Daggett-Vondras, Juliane, Torres, Lino, Christie, John, Appel, Nicole, Cox, Anna L., Kim, Jae B., McFadden, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364119/
https://www.ncbi.nlm.nih.gov/pubmed/32695875
http://dx.doi.org/10.1016/j.omto.2020.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364119/
https://www.ncbi.nlm.nih.gov/pubmed/32695875
http://dx.doi.org/10.1016/j.omto.2020.06.011

Ejemplares similares